Invention Grant
- Patent Title: Modulation of nerves innervating the liver
-
Application No.: US16119090Application Date: 2018-08-31
-
Publication No.: US10543034B2Publication Date: 2020-01-28
- Inventor: Bobak Robert Azamian , Scott Bradley Vafai
- Applicant: Metavention, Inc.
- Applicant Address: US MN Maple Grove
- Assignee: Metavention, Inc.
- Current Assignee: Metavention, Inc.
- Current Assignee Address: US MN Maple Grove
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: A61B18/02
- IPC: A61B18/02 ; A61B18/24 ; A61B18/14 ; A61N5/00 ; A61B17/00 ; A61B17/32 ; A61B18/04 ; A61B18/06 ; A61N7/00 ; A61B18/18 ; A61B18/20 ; A61M5/14 ; A61K31/045 ; A61K31/05 ; A61K31/395 ; A61K33/30 ; A61K45/06 ; A61K9/00 ; A61N1/05 ; A61N7/02 ; A61B18/00

Abstract:
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Public/Granted literature
- US20190059969A1 CHEMICAL MODULATION OF NERVES INNERVATING THE LIVER Public/Granted day:2019-02-28
Information query